From: 24/03/2017 to: 24/03/2017 4th ESO Prostate Cancer Observatory: innovation and care in the next 12 months, London, United Kingdom                                        From: 25/03/2017 to: 30/03/2017 16th ESO-ESMO Masterclass in Clinical Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 25/03/2017 to: 30/03/2017 10th ESO-EONS Masterclass in Oncology Nursing, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 12/04/2017 to: 13/04/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 26/04/2017 to: 30/04/2017 3rd ESO-ESMO Latin-American Masterclass in Clinical Oncology, San Jose, Costa Rica                                        From: 7/05/2017 to: 7/05/2017 4th ESO Lung Cancer Observatory, Geneva, Switzerland                                        From: 18/05/2017 to: 19/05/2017 Eurasia Course on Gastrointestinal Malignancies, Moscow, Russian Federation                                        From: 22/05/2017 to: 26/05/2017 3rd ESOP-ESO Advanced Masterclass in Oncology Pharmacy, Lisbon, Portugal                                        From: 26/05/2017 to: 27/05/2017 ESMO Preceptorship on Immuno-Oncology 2017, Amsterdam, The Netherlands                                        From: 10/06/2017 to: 13/06/2017 Leukaemia and Lymphoma, Ascona, Switzerland                                        From: 21/06/2017 to: 23/06/2017 Masterclass in Oncology Basics for Beginners, Cambridge, United Kingdom                                        From: 30/06/2017 to: 05/07/2017 4th ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology, Belgrade, Serbia                                        From: 13/07/2017 to: 18/07/2017 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 1st Mediterranean Masterclass in Clinical Oncology, Limassol, Cyprus

Industry Support


As an independent, non-profit organisation which has the mission to decrease cancer deaths due to lack of knowledge, the European School of Oncology (ESO) is committed to working with all stakeholder groups to try to improve cancer outcomes. The School recognises that different industries make an important contribution to improving cancer outcomes through the development of innovative technologies including diagnostics, imaging, surgical  and radiotherapy equipment, and medicines. For this reason ESO fosters on-going dialogue and collaboration with industry partners.  

In July 2004 ESO established the Sharing Progress in Cancer Care (SPCC) programme in order to facilitate its interactions with industry partners. SPCC partners are required to make an annual unrestricted donation to the School. Donations from SPCC partners are pooled and used to support a number of ESO initiatives including the Masterclass in Clinical Oncology, Cancer World magazine and free or low-fee educational events. Many of these events are held in low- to middle-income countries, which are not well served by other providers of cancer education. In addition, ESO gives SPCC partners  the opportunity to propose collaborative projects, which are only accepted if they are aligned with ESO's mission, have multi-sponsors and address a clear unmet educational need.   

The School maintains total editorial control over the planning and execution of all ESO projects. SPCC partners may be invited to contribute ideas, as appropriate, but decisions about procedures and content are made by ESO.

Donations from SPCC partners represent no more than 25% of ESO's annual budget. The rest of ESO's funding comes from its two sustaining foundations, royalties, income from conferences and donations from individual supporters.

The companies that are currently member of the SPCC programme are:

           

 Boehringer Ingelheim     
 Merck KGaA, Darmstadt, Germany
 Bristol-Myers Squibb     
 Novartis
 Celgene Corporation       Pfizer
 Genomic Health     
 Roche
 Helsinn      Sandoz Biopharmaceutical
 Lilly     
 


Sharing Progress in Cancer Care
Department Coordinator

Matti Aapro, Geneva

For further information please contact Daniela Mengato at dmengato@eso.net